AZTREONAM FOR INHALATION SOLUTION (AZLI) TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS (CF) AND CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION

被引：0
|
作者：
Accurso, F. J. [1 ]
Fayon, M. [2 ]
Sermet, I. [3 ]
Lewis, S. [4 ]
Bresnik, M. [5 ]
Oermann, C. M. [6 ]
机构：
[1] UCD Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[2] CHU Bordeaux, CIC 0005, Bordeaux, France
[3] Hop Necker Enfants Malad, CHU Paris, Paris, France
[4] Gilead Sci Inc, Seattle, WA USA
[5] Gilead Sci Inc, Foster City, CA 94404 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
来源：
PEDIATRIC PULMONOLOGY | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [41] Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis
    Lebecque, Patrick
    Leal, Teresinha
    Zylberberg, Katia
    Reychler, Gregory
    Bossuyt, Xavier
    Godding, Veronique
    JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (04) : 237 - 244
  • [42] Host adaptation of Pseudomonas aeruginosa during chronic infection of the cystic fibrosis (CF) lung.
    Hogardt, M.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 : 29 - 30
  • [43] Risk factors for early acquisition of pseudomonas aeruginosa endobronchial infection in cystic fibrosis (cf) children
    Reid A.
    McCaughen J.
    Shields M.D.
    Redmond A.
    Pediatric Research, 1998, 44 (3) : 457 - 457
  • [44] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
    Braccini, G.
    Festini, F.
    Boni, V.
    Neri, A. S.
    Galici, V.
    Campana, S.
    Zavataro, L.
    Trevisan, F.
    Braggion, C.
    Taccetti, G.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
  • [45] A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) infection for pharmacokinetic and therapeutic equivalence
    Sands, Dorota
    Sapiejka, Ewa
    Mazurek, Henryk
    Gaszczyk, Grzegorz
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [46] Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study
    Blasi, Francesco
    Carnovale, Vincenzo
    Cimino, Giuseppe
    Lucidi, Vincenzina
    Salvatore, Donatello
    Messore, Barbara
    Bartezaghi, Marta
    Muscianisi, Elisa
    Porpiglia, Pasquale Alberto
    RESPIRATORY MEDICINE, 2018, 138 : 88 - 94
  • [47] THE SOCIAL NETWORK IN CYSTIC FIBROSIS (CF) CENTRE CARE AND THE RISK OF SHARED PSEUDOMONAS AERUGINOSA (PA) STRAIN INFECTION
    Kidd, T. J.
    Magalhaes, R. J. Soares
    Paynter, S.
    Bell, S. C.
    RESPIROLOGY, 2013, 18 : 11 - 11
  • [48] Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis
    Somayaji, Ranjani
    Parkins, Michael D.
    THERAPEUTIC DELIVERY, 2015, 6 (02) : 121 - 137
  • [49] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT
    Hewer, Simon C. Langton
    Smyth, Alan R.
    Brown, Michaela
    Jones, Ashley P.
    Hickey, Helen
    Kenna, Dervla
    Ashby, Deborah
    Thompson, Alexander
    Sutton, Laura
    Clayton, Dannii
    Arch, Barbara
    Tanajewski, Lukasz
    Berdunov, Vladislav
    Williamson, Paula R.
    HEALTH TECHNOLOGY ASSESSMENT, 2021, 25 (65) : 1 - +
  • [50] Successful Eradication of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
    Singh, J. A.
    Lynch, S.
    Iredell, J.
    Selvadurai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345